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The genes of the major histocompatibility complex code for the histocompati- 
bility antigens as well as control the immune response to certain antigens. The 
human histocompatibility  (HLA) antigens  are glycoprotein components of the 
plasma membrane.  These antigens are the major recognition sites of immuno- 
logical  identity  and  are  responsible  for  the  induction  of allograft  rejection. 
Certain HLA antigen types are known to correlate with an individual's suscepti- 
bility and immunological responsiveness to virus infection (1-5). Examples are 
the elevation of measles virus antibody levels (1,  4) and the enhanced risk of 
developing paralytic  poliomyelitis  (2)  in individuals  of HLA-A3  and  HLA-B7 
specificities. Theoretically, viruses can induce an autoimmune response either 
by modifying HLA antigens during the course of virus infection or by incorporat- 
ing  altered  HLA antigens  into  the  envelope of maturing  virions  (5).  Recent 
interest has focused on the major histocompatibility (H-2) antigens in the mouse 
in a variety of virus infections. Evidence has accumulated that H-2 compatibil- 
ity between the  effector thymus-derived  (T)  cytotoxic lymphocyte and the in- 
fected target cell is a  prerequisite for destruction of virus-infected cells (6-10). 
The mechanism of this restricted cell-cell recognition is not clear. On the basis of 
co-capping experiments,  it has been suggested that there is a physical associa- 
tion between oncornavirus cell surface antigens and H-2 determinants  (11). 
HLA antigens are host cell surface markers that can be followed easily during 
the  course  of virus  infection.  Therefore,  we  studied  the  interaction  of HLA 
antigens with measles virus 'antigens  expressed on the surfaces of a  variety of 
cells.  The  concentration  of HLA antigens  on the  surfaces of cultured  human 
lymphoblastoid cells was unchanged by infecting cells with measles virus. The 
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large  amounts of virus antigens  inserted  into the cells'  membranes  remained 
physically  independent  from HLA antigens.  HLA antigens  appear  neither to 
serve as receptors  for measles virus nor to be incorporated  into the maturing 
virus  particle.  In  contrast  to  measles  virus  infection,  infection  of cultured 
human lymphoblastoid cells  with poliomyelitis  virus and vesicular  stomatitis 
virus (VSV) 1 was found to decrease the concentration of HLA antigens. 
Materials and Methods 
Virus.  Wild-type  Edmonston  measles  virus  originally  obtained  from  the  American  Type 
Culture Collection, Rockville, Md.  was maintained in this laboratory by passage through HeLa 
cells. The virus was harvested by sonic oscillation and clarified by low speed centrifugation. The 
virus  was  assayed  on  BSC-1  cell  monolayers  as  previously  reported  (12).  The  VSV  (Indiana 
serotype) and poliovirus type 1 were obtained from Dr. John Holland, University of California at 
San Diego, La Jolla, Calif. The VSV was grown and assayed on L-929 cells, while the poliovirus 
was grown and assayed on HeLa cells. The techniques were adapted from those used for measles 
virus (12). 
Infection of  Human Lymphoblastoid Cells.  Daudi (no detectable HLA), WI-L2 (HLA-A1, HLA- 
A2,  HLA-B5,  and HLA-B17),  and RPMI-8866 (HLA-A2,  HLA-A3,  HLA-B7,  and HLA-B12) cells 
were  grown  in  suspension  in  RPMI-1640  medium  supplemented  with  10%  fetal  calf serum, 
glutamine, and antibiotics. Raji (HLA-A3 and HLA-BW35) cells were grown in Eagle's minimal 
essential medium with the same additives. To initiate infection the cells were suspended in the 
virus stock and infected with measles virus [multiplicity of infection (MOI) =  1], VSV (MOI =  10), 
or poliovirus  1  (MOI  =  100)  by incubation at  37°C  for 2  h  on an inverted shaker.  After virus 
adsorption the cells were diluted with medium to 2  ×  10  s cells/ml. 
HLA Antisera.  The alloantisera Gaulier 1-01-8-12-22-02  (anti-HLA-A1), Bizot 1-01-8-12-22-03F 
(anti-HLA-A2), Stackenburg 1-04-0-02-10-02  (anti-HLA-A2), Storm 2-50-6-02-22-01  (anti-HLA-A3), 
Victor 1-01-9-0%17-04  (anti-HLA-B5), Melnikoff 2-57-9-03-14-08  (anti-HLA-B7), and Willet 2-51-2- 
04-27-01  (anti-HLA-BS) were obtained from the serum bank at the National Institute of Allergy 
and Infectious Diseases, Bethesda, Md. The anti-HLA-A9 serum Grubisch was obtained from Dr. 
Edmond Yunis, Harvard Medical School, Boston, Mass. 
Surface Immunofluoreseence.  Approximately  1  ×  10  s  infected and  uninfected viable  cells, 
suspended in 20/~1 of antiserum, were agitated for 30 min at room temperature. After two washes 
of the  cell  pellet,  the  cells  were  then  incubated in  an  appropriate  fiuorescein  isothiocyanate 
(FITC)-conjugated antiserum. Each cell pellet was then washed three additional times.  Measles 
virus antigens were detected by direct immunofluorescence, while VSV and HLA antigens were 
demonstrated by the indirect method. The techniques and specificity of the various reagents have 
been previously reported (13,  14). 
Microcytotoxicity.  Human alloantisera were titrated for cytotoxic antibody to HLA antigens 
by a modification (15) of the microcytetoxicity assay of Mittal et al. (16).  Briefly, approximately 1 
×  103 human peripheral lymphocytes were incubated at room temperature for 30 min with diluted 
antisera in Meller-Coates plates.  After the addition of rabbit complement  (C) the  plates were 
incubated at room temperature for an additional 3 h. After the addition of eosin and formalin, the 
percent of C-lysed (eosin-stained) cells was determined by phase microscopy. The highest dilution 
of antiserum to lyse over 90% of the target cells was defined as the cytotoxic end point. 
Quantitation  of Surface HLA Antigens.  Surface HLA antigens were quantified, as previously 
reported (17) by a microabsorption technique. In brief, various concentrations of washed cells (300- 
50,000) were incubated for 1 h at room temperature with an equal volume of antiserum at twice the 
cytotoxic  end-point concentration.  After centrifugation,  the residual  cytotoxic  antibody in the 
supernate was again determined. The percent absorption was defined as:  [1  -  (% cell lysis by 
absorbed serum)/(% cell lysis by unabsorbed serum)]  ×  100. 
Depletion of Measles Antibody.  Anti-HLA-A2 (Bizot) serum was incubated overnight at 4°C 
; Abbreviations used in this paper: ADso adsorption of 50% antibody; EMC, encephalomyocardi- 
tis; FITC, fluorescein isothiocyanate; MOI, multiplicity of infection; PFU, plaque-forming units; 
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with approximately 1 x  108 measles virus-infected Raji (HLA-A3 and HLA-BW 35) or Daudi (no 
detectable HLA type) cells and then centrifuged at 5,400g for 5 min. The procedure was repeated 
until the antiserum was depleted of measles antibody, as detected by indirect immunofluores- 
cence. No decrease in the titer of cytotoxic antibody directed against HLA-A2 was observed after 
these absorptions. 
Co-Capping  of Surface Antigens.  WI-L2  cells (HLA-A2),  48  h  after infection with measles 
virus (MOI = 3), were incubated for 30 min at 37°C with anti-HLA-A2 serum previously depleted of 
measles antibody. After two washes of this cell pellet, the cells were incubated at 37°C for 30 min 
with rabbit anti-human Ig conjugated with FITC.  The cells were washed four times with cold 
medium and then incubated at 4°C with rhodamine-labeled  human anti-measles serum for 30 rain. 
After thorough  washing, the  cells were examined for patterns of rhodamine and fluorescein 
fluorescence with a  Zeiss fluorescence microscope (Carl Zeiss, Inc., N. Y.)  (18). 
Electron Microscopy.  The surfaces of RPMI-8866 and WI-L2 cells were examined for measles 
virus antigens 48 h  after infection (MOI  =  1), after incubation with normal human serum for 30 
min at room temperature. Human anti-HLA-A2 serum, depleted of detectable measles antibody, 
was used to detect HLA-A2 antigen. The cells were washed twice and then incubated with ferritin- 
labeled goat anti-human Ig. The cell pellet was washed seven times and the ceils were fixed with 
2.5% phosphate-buffered  glutaraldehyde and processed for electron microscopy. 
Treatment of Measles  Virus with HLA-A2 Antibody and C.  Measles virus, grown in RPMI- 
8866 cells, was diluted with medium to 1.4 ×  10  ~ plaque-forming units (PFU)/ml. 100 ~l of human 
anti-HLA-A2 serum,  previously depleted of detectable measles antibody,  and 400  ~1  of a  1:2 
dilution of guinea pig C in medium were mixed with 400 ~l of virus. As a control, fetal calf serum 
was  substituted for the  HLA-A2  antisera.  After incubation at  37°C for 30  rain,  the residual 
infectivity was assayed on BSC-1 cell monolayers. 
Measles Virus Infection  of WI-L2 Cells Pretreated with HLA-A2 Antibody.  WI-L2 cells (HLA- 
A2) were incubated at room temperature for 30 min with an excess of human anti-HLA-A2 serum 
previously depleted of detectable measles antibody. Control cells were incubated with fetal calf 
serum. The cells, in the presence of HLA-A2 antibody, were infected with measles virus (MOI = 
10) and agitated for i h at 37°C. The preparation was monitored by immunofluorescence  for excess 
HLA-A2 antibody as well as for retention of cell membrane-bound antibody after virus adsorption. 
The supernate was also assayed for residual infectious measles virus. Similarly, Daudi cells which 
express Ig on their surfaces were incubated with rabbit antibody to human Ig and then infected 
with measles virus. The cells were washed twice, suspended in medium at 4  ×  105 cells/ml, and 
incubated at 37°C. After 18 h, yields of infectious virus were determined by plaque assay and the 
proportion of cells expressing measles virus antigens on their surfaces was determined by direct 
immunofluorescence. 
Results 
The Effect of Measles Virus upon HLA Expression.  WI-L2, Raji, and RPMI- 
8866 cells were infected with measles virus at an MOI of 1.48 h after initiation of 
infection, measles virus antigens were detected on the surfaces of greater than 
90% of the infected cells, while the viabilities of virus-infected and uninfected 
cells were similar (greater than 90%). The number of infected or uninfected cells 
required to absorb 50%  (ADso) of the cytotoxic antibody was determined using 
the  appropriate  human  alloantisera.  As  seen  in  Fig.  1,  equal  numbers  of 
measles virus-infected and uninfected cells were required to absorb 50% of the 
HLA-directed antisera.  The cytotoxic antibody directed against HLA-A2 was 
reduced by 50% after absorption with 450 measles virus-infected or uninfected 
WI-L2 cells; the AD~0 for HLA-A3 serum was 1,100 uninfected and 1,400 measles 
virus-infected Raji cells. Absorption with 420 uninfected or 480 measles virus- 
infected RPMI-8866  cells reduced the anti-HLA-B7 cytotoxic antibody titer by 
50%. Thus,  the  amount of HLA antigen expressed  on the  surfaces of these 
lymphoblastoid cells was not significantly changed after infection with measles 
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Fro.  1.  The absorption of cytotoxic HLA-directed antibody by measles virus-infected and 
uninfected lymphoblastoid cells. Cell surface HLA antigens were quantified by a  microab- 
sorption technique as described in the Materials and Methods. Cells infected with measles 
virus were assayed 48 h after infection at a MOI of 1. The percent absorption was defined  as 
[1  -  (% cell lysis by absorbed serum)/(% cell lysis by unabsorbed serum)]  x  100. 
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To determine whether alterations in HLA specificity may occur during infec- 
tion,  Raji cells were infected with measles virus and then incubated with sera 
directed  against  six  other  HLA  specificities.  Absorption  of these  sera  with 
100,000  measles virus infected Raji cells failed to reduce the cytotoxic antibody 
titers (Table I). Hence, infection of Raji cells with measles virus did not reduce 
the ability of these cells to absorb HLA-A3 antibodies or induce the appearance 
of six other HLA antigens. 
The Effect of VSV or Poliovirus Infection and Puromycin  Treatment upon 
HLA Expression.  WI-L2 cells infected with either  VSV (MOI  --  10) or polio- 
virus type 1 (MOI =  100) or incubated with puromycin (50/zg/ml) were assayed 
for surface HLA-A2 antigen  after 12 h.  The viability of the VSW-infected and 
puromycin-treated cells were comparable to the uninfected control cells (greater 
than  or equal  to  90%)  while the  viability of the  poliovirus-infected cells  was 
about  70%.  As  shown  in  Table  II,  both  these  virus  infections  or  puromycin 
treatment reduced the amount of HLA-A2 50-70% by 12 h. Inhibition of cellular 
protein synthesis,  either by virus infection or treatment  with puromycin pro- 
duced similar decreases in HLA-A2. 
Physical Relationship  between  Measles  Virus and HLA-A2 Antigen on the 
Surface of Infected Cells.  WI-L2 cells infected with measles virus were incu- 
bated under conditions favoring capping with human anti-HLA-A2 sera (previ- 
ously depleted of measles virus antibody), goat anti-human  Ig conjugated with 
FITC, and rhodamine-labeled human antibody to measles virus. As seen in Fig. 
2, considerable divergence in the localization of the rhodamine-labeled measles 
antigens and fluorescein-labeled HLA-A2 antigens on the surface of WI-L2 cells 
occurred. Next the localization of measles virus and HLA surface antigens were 
mapped by immunoelectron microscopy. Measles virus antigens were found on 
the  outer plasma  membrane  of infected cells above aligned  nucleocapsid-like 
structures  (Fig.  3 A).  HLA-A2 antigens,  detected by human alloantiserum  de- 
pleted of measles antibody,  were located at membrane  sites distinct from the 
maturing measles virions on several cell lines  (Figs.  3 B and 3 C). No HLA-A2 
antigens were detected on the surface of budding measles virions. 150  HLA  ANTIGENS  AND  MEASLES  VIRUS  INFECTION 
TABLE  I 
The Effect of Measles Virus Infection upon Expression of HLA 
Antigens on the Surfaces of Raji Cells 
Specificity of  HLA  allo- 
antiserum 
Number  of  Raji cells  to absorb 50% cytotoxic 
antibody 
Measles-virus in-  Uninfected 
fected* 
HLA-A1  >i00,000  >100,000 
HLA-A2  >I00,000  >I00,000 
HLA-A3  1,400  1,600 
HLA-B5  >i00,000  >I00,000 
HLA-B7  >i00,000  >i00,000 
HLA-B8  >i00,000  >i00,000 
HLA-A9  >I00,000  >I00,000 
* Raji cells (HLA-A3 and HLA-BW35) were infected with measles virus 
(MOI =  1) and examined 48 h later for absorption of cytotexic antibody 
as described in the Materials and Methods. 
TABLE  II 
The Effect of  Puromycin Treatment or Measles Virus, Poliovirus, 
or VSV Infection on Surface HLA-A2 of WI-L2 Cells 
Treatment  Exp. no.  AD50 ratio*  %  Reduction* 
Measles virus§  1  800/800  0 
2  300/300  0 
3  1,000/1,200  17 
4  300/300  0 (4.3)tl 
Poliovirus type 1¶  1  600/1,500  60 
2  500/1,500  67 
3  500/1,500  67 
4  500/1,150  57 (63) 
Puromycin**  1  800/2,250  64 
2  300/1,000  70 
3  1,000/2,000  50 
4  300/900  67 (63) 
VSV*~  1  800/1,800  56 
2  300/600  50 
3  1,000/2,100  52 
4  300/900  67 (56) 
* The number of  treated and control cells  required to AD~o of  the anti- 
HLA-A2  cytotoxic antibody as described in the Materials and Meth- 
ods. The numerator of  the ratio is  the ADso for  the control cells  while 
the denominator is the ADs0 of  the treated cells.  WI-L2 cells  express 
HLA-A1,  HLA-A2,  HLA-B5,  and HLA-B17  on their surfaces. 
* (1-ADso ratio) × 100. 
§ Measles  virus-infected  (MOI  =  1) cells were  assayed  48 h  after 
infection. 
II Average reduction. 
¶ Poliovirus-infected (MOI =  100)  cells  were assayed 12 h after  infec- 
tion. 
** Puromycin  (50 ~g/ml) was incubated with cells  for 12 h. 
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FIG. 2.  The immunofluorescent localization  of  measles virus and HLA  antigens on the 
surfaces  of  WI-L2  cells.  WI-L2  cells,  48  h aRer  infection  with  measles  virus  (MOI = 3),  were 
incubated  with  human HLA-A2 alloantiserum depleted  of  detectable  measles  antibody and 
rabbit  anti-human  IgG  labeled  with  fiuorescein.  The  cells  were  then  exposed  to  human anti- 
measles serum labeled  with rhodamine. The dissimilar  localizations  of  HLA-A2 antigens 
and measles virus antigens  on the same cell  are seen clearly  when viewed through 
rhodamine-(right) and fluorescein-sensitive  (left)  filters. 
To determine whether HLA-A2 antigens occurred on the surfaces of infectious 
measles virions, measles virus grown in RPMI-8866  cells (containing HLA-A2) 
was incubated with HLA-A2-directed alloantiserum (previously depleted of mea- 
sles antibody) and guinea pig C.  No significant differences in plaque numbers 
were observed between virus treated with HLA-A2 antibody (average = 64) and 
virus treated with control  (fetal calf)  serum  (average  =  69). Thus,  utilizing 
several different techniques,  HLA antigens were not detected in association 
with measles virus antigens on either the surface of infected cells or on the 
envelope of mature infectious virions. 
The Effect of Pretreating  WI-L2 Cells  with Antibody  to HLA-A2 Determi- 
nants and Daudi Cells with Antibody to Human Ig upon Measles Virus Adsorp- 
tion.  WI-L2 cells contain HLA-A2 and Daudi cells contain human Ig determi- 
nants on their surfaces, respectively. Initially WI-L2 cells were incubated with 
an excess of antibody to HLA-A2 and Daudi cells with rabbit antibody directed 
against human Ig. As a control, WI-L2 and Daudi cells were treated with fetal 
calf serum. After 1 h incubation, the cells were infected with measles virus. At 
that time 100% of  the WI-L2 cells and 85% of  the Daudi cells exhibited anti-HLA 
and anti-human Ig antibodies, respectively, bound to their surfaces.  No  cell 
clumps were observed after the addition of measles virus to the antibody-treated 
cells. Sufficient infectious virus remained after virus adsorption to be able to 
infect a  similar number  of cells  at  a  MOI  of 1.  After virus adsorption,  the 
majority of the cells were found to have retained the appropriate antibody. 18 h 
after infection, 54%  of the WI-L2 cells pretreated with HLA-A2 antibody ex- 
pressed  measles  virus  antigens,  whereas  69%  of control  cells  did.  Yields  of 
infectious measles virus from HLA-A2 antibody-treated WI-L2 cells was 0.12 
PFU per viable cell while control cells synthesized 0.18  PFU per viable cell. 
Similarly, 79%  of Daudi  cells  initially treated with anti-human Ig antibody FIG.  3.  Measles virus antigen and HLA-A2 antigen localization on the surfaces of RPMI- 
8866  (A  and  B)  and  WI-L2  (C)  cells.  Cell  preparation  A  was  exposed first to  human 
antibodies against measles virus,  then to ferritin-labeled goat anti-human IgG, whereas 
preparations B and C were exposed first to human anti-HLA-A2 serum depleted of detecta- 
ble measles antibody, then to ferritin-conjugated goat anti-human IgG.  Arrows point to 
fuzzy nucleocapsids that have aligned under those areas of the plasma membrane that have 
been modified by the insertion of measles virus antigens. HLA-A2 and measles surface 
antigens are localized at distinctly different membrane sites on both RPMI-8866 (B) and WI- 
L2 (C) cells (x  120,000). 
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expressed measles virus surface antigens as compared to 95% of control Daudi 
cells.  Antibody-treated  Daudi  cells  synthesized  0.74  PFU  per  viable  cell  as 
compared to 1.1  PFU per viable cell for control cells.  Hence, cells coated with 
anti-HLA-A2 antibody were as susceptible to productive measles virus infection 
as noncoated cells or cells coated with antibody to human Ig. 
Discussion 
In this paper we describe the relationship between measles virus antigens on 
the  cell's  surface  and  the  expression  of surface  HLA  antigens.  Using  three 
lymphoblastoid cell lines of different HLA phenotypes, we found that there was 
no significant reduction in the quantity of HLA determinants  during infection 
with measles virus. In contrast, WI-L2 cells infected with VSV or poliovirus type 
1 exhibited a  50-70% decrease in surface HLA antigens.  Puromycin treatment 
(50  ~g/ml)  was  associated  with  a  similar  decrease  in  HLA  expression.  In 
addition we noted no alteration in the specific binding of HLA-directed antibody 
during measles virus infection. Measles virus-infected Raji cells and uninfected 
Raji  cells  absorbed  antibody  directed  to  the  same  HLA  speciflcities.  These 
results contrast  with the report that  some human  cells transformed by SV40 
virus  expressed  an  HLA specificity  (HLA-B5) not present  on the  surfaces  of 
uninfected  cells  (19).  There  are  conflicting reports  of altered  H-2 specificities 
after infection with vaccinia virus (reference 20 and R. M. Zinkernagel,  unpub- 
lished  data).  Thus,  results  with  one virus infection  cannot  be generalized  to 
other virus infections. 
Hecht and Summers reported that after infection with VSV, a budding RNA 
virus that  inserts  virus glycoproteins into the cell's membrane,  murine  L-929 
cells  exhibited  decreased  amounts  of surface  H-2k  antigens  (21).  They  also 
studied the effects of actinomycin D or cyclohexamide treatment and encephalo- 
myocarditis (EMC) virus, a nonbudding RNA virus, on H-2k expression in L-929 
cells. They found no significant decrease in H-2k despite the inhibition  of cell 
protein synthesis of over 95% (21). These results have been interpreted to mean 
that the decrease of H-2k antigens  during  VSV infection is a  result  of virus- 
induced  modification of the  cell membrane.  In contrast,  our data  suggest an 
alternative explanation.  The decrease in H-2 observed by Hecht and Summers 
and the decrease in HLA observed by us with VSV and poliovirus infection most 
likely  reflects  an  inhibition  of host  protein  synthesis  and  not  virus-induced 
modification of the cell membrane.  First, we found that despite the insertion of 
large amount of measles virus antigens into the cell membrane,  quantities  of 
HLA antigens  remained  at  pre-infection  levels.  Other  experiments  not  pre- 
sented here demonstrated that infection of these cells with measles virus did not 
significantly inhibit host protein synthesis (less than 15%) (M. V. Haspel and M. 
B. A. Oldstone, unpublished data).  Second, poliovirus, which is related to EMC 
virus,  inhibited  host  protein  synthesis  and  reduced  the  amount  of HLA-A2 
antigen  expressed at the cell's surface without the insertion of virus-specified 
antigens into the cell membrane. Third, treatment of WI-L2 cells with cyclohex- 
amide  or  actinomycin  D  did  not  affect  the  expression  of HLA-A2,  whereas 
puromycin treatment decreased the amount of surface HLA (22). Fourth, other 
viruses such as Newcastle disease virus (23,  24) and vaccinia virus (20),  which 
inhibit host protein synthesis, also decrease H-2 antigens on the cell's surface. 154  HLA  ANTIGENS  AND  MEASLES  VIRUS  INFECTION 
Although  large  amounts  of measles  virus  antigens  were  inserted  into  the 
plasma  membrane  of infected cells,  the  virus antigens  were physically inde- 
pendent of the HLA antigens. In tests for co-capping, labeled virus antigens and 
labeled HLA localized separately on the same cell.  These experiments showed 
the independence of virus antigens from HLA since if they were linked,  move- 
ment of one antigen in a  membrane would pull the other antigen with it. 
Measles  virus  antigens  were  observed  by  immunoelectron  microscopy  at 
plasma membrane sites devoid of detectable HLA antigens.  This separation of 
HLA and  measles  virus antigens  was consistently  observed in over 100 cells 
studied in two different lymphoblastoid cell lines.  These findings were further 
confirmed when the infectious titer of measles virus grown in HLA-A2 cells was 
not significantly reduced after incubation with antibody directed against HLA- 
A2  and  C.  In  concert  with  our findings,  HLA  antigens  are  not  detected  by 
electron  microscopy on  the  envelope of Epstein-Barr  virus  (25),  nor  are  H-2 
antigens  frequently  (4-5%)  observed on the surface of murine  leukemia  virus 
particles  (26).  Although murine leukemia virus particles seem to be independ- 
ent of the histocompatibility complex during  the maturation  of virus through 
the  plasma  membrane,  the  co-capping  of Friend  leukemia  virus  gp69  and 
antibodies directed towards the major H-2  complex has recently been reported 
(11).  These discrepancies should be resolved in future experiments.  Hecht and 
Summers have reported that H-2k antigens were associated with purified prepa- 
rations of VSV (27). In this latter case it is not clear whether this association is 
with  a  mature  infectious  virion  or  rather  with  some  aberrant  uninfectious 
particles. 
It seemed possible that although HLA antigens do not appear to be involved in 
the maturation of measles virus, HLA antigens could play an integral role in the 
adsorption of measles virus (i.e., serve as or be spatially related to measles virus 
receptor sites). The incubation of WI-L2 cells with an excess of HLA-A2-directed 
antibody did not abrogate measles virus infection of these cells. The differences 
observed  between  HLA-directed  antibody-treated  cells  and  control  serum- 
treated cells probably reflects a  steric hindrance  by the large quantities of cell 
membrane-bound  antibody,  since  Daudi  cells,  which  bear surface  Ig,  behave 
similarly when treated with rabbit antibody directed against human Ig before 
measles virus infection. 
Our  studies  demonstrate  that  HLA antigens  neither  serve as  the  receptor 
sites nor maturation  sites for measles virus.  HLA antigens  remain  quantita- 
tively unaltered during the course of measles virus infection.  Previous studies 
demonstrated that measles virus replication is not influenced by a specific HLA 
phenotype expressed on the surfaces of a  variety of cultured cells (28).  Hence, 
the enhanced immune response of individuals of certain HLA types to measles 
virus is unlikely to be explained on the basis of measles virus replication and its 
control by HLA antigens.  Possibly, the reported differences in susceptibility to 
disease  associated  with  specific  HLA  haplotypes  may  in  fact  be  related  to 
immune response genes closely linked to HLA antigens. 
Summary 
Histocompatibility  antigens  on  the  surface  of human  lymphoblastoid  cells 
were quantified by a  microadsorption technique.  During the course of measles HASPEL,  PELLEGRINO,  LAMPERT, AND  OLDSTONE  155 
virus infection,  no quantitative or qualitative alterations in surface HLA anti- 
gens were  observed.  In contrast,  infection  with  poliovirus type  1 or vesicular 
stomatitis virus, or treatment with puromycin (50 ~g/ml) resulted in a  signifi- 
cant decrease in surface HLA. These experiments suggest that an inhibition of 
host protein synthesis rather than the insertion of virus-specified antigens into 
the membrane results in a  net decrease in amounts of this cell surface antigen. 
The HLA antigens also appear to be both functionally and structurally distinct 
from measles virus surface antigens.  Pretreatment of cells with HLA-directed 
antibody did not prevent the infection of these cells by measles virus, thus HLA 
antigens  appear  unrelated  to  the  measles  virus  receptor  site  on  the  plasma 
membrane.  Electron  microscopic studies  revealed that  measles virus  matura- 
tion occurs at membrane sites devoid of demonstrable HLA. Furthermore,  HLA 
antigens could not be detected on the surfaces of mature infectious virions. 
We thank Anna Pellegrino  and Peggy Farness for their superb technical assistance, and Phyllis 
Minick and Sally Hendrix for manuscript preparation. 
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